| Drivers of Eosinophilic COPD Exacerbations (NCT04961060) | University Medical Center Groningen | 2021-07-01 |
| Home Air Purification for Eosinophilic COPD (NCT04252235) | Beth Israel Deaconess Medical Center | 2021-03-15 |
| Mepolizumab in Episodic Angioedema With Eosinophilia (NCT04128371) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-01-14 |
| Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial (NCT04075331) | University of Leicester | 2020-09-07 |
| Clinical Characteristics and Treatment of Chest Tightness Variant Asthma (NCT04322422) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-06-01 |
| Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders (NCT03801434) | William Shomali | 2019-11-15 |
| Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma. (NCT03989635) | Novartis Pharmaceuticals | 2019-10-15 |
| Natural History of Hypereosinophilia and Hypereosinophilic Syndromes (NCT04018118) | University Hospital, Lille | 2019-05-06 |
| Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis (NCT03450083) | Johns Hopkins University | 2017-07-01 |
| Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma (NCT03237221) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2015-03-01 |
| Functional Dyspepsia (FD) - Clinical Response to Montelukast in Children (NCT02360696) | Children's Mercy Hospital Kansas City | 2014-08-01 |
| Steroid Treatment for Hypereosinophilic Syndrome (NCT01524536) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-02-16 |
| Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index (NCT00939263) | Insel Gruppe AG, University Hospital Bern | 2011-01-01 |
| A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression (NCT00091871) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-08 |
| Phase II Gleevec Idiopathic Hypereosinophilic Syndrome (NCT00230334) | Steven E. Coutre | 2003-06-12 |
| Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia (NCT00001406) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-04-21 |